Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression. Wang F, Li J, Wang H, Zhang F, et al. Int J Oncol 2020 Jun 19. doi: 10.3892/ijo.2020.5084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang F, Li J, Wang H, Zhang F, et al. Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression. Int J Oncol 2020 Jun 19. doi: 10.3892/ijo.2020.5084.
PMID: 32582999